AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

It was tested in a prospective, single-blind study of 200 heart patients against the standard traditional 12-lead EKG procedure ... you don't have to wheel the machine in, you don't have to ...

The device requires minimal self-guided training and is simpler and faster to use than standard 12-lead ECG machines. These features put 12-lead ECG data within reach of more healthcare providers ...

Using machine learning algorithms, the team built a model that could take a patient's 12-lead ECG and predict whether they would or would not develop AFib. The model correctly classified 80% of ...

Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. "AliveCor's Kardia 12L ECG System was born from our vision to leverage AI and ...

The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...

The results indicated that Kardia 12L ECG System (with its reduced leadset) performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities, including bundle ...